Veracyte(DE:12V)
€22.71+1.39 (+6.52%)
DE:12V
Veracyte financials statements
€22.71
At close:+1.39 (+6.52%)
Veracyte (12V) Ratios
3 Followers
Veracyte Ratios
DE:12V's free cash flow for Q3 2026 was $37.92M. For the 2026 fiscal year, DE:12V's free cash flow was decreased by $-2.33M and operating cash flow was $40.26M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.15 | 4.73 | 4.66 | 3.97 | 3.79 |
| Quick Ratio | 7.81 | 4.46 | 4.40 | 3.74 | 3.61 |
| Cash Ratio | 6.05 | 3.04 | 3.53 | 2.46 | 2.70 |
| Solvency Ratio | 0.91 | 0.38 | -0.67 | -0.09 | -0.60 |
| Operating Cash Flow Ratio | 2.27 | 0.96 | 0.72 | 0.12 | -0.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -28.06 |
| Net Current Asset Value | $ 391.93M | $ 248.20M | $ 214.82M | $ 167.41M | $ 151.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.07 | 1.11 | 1.07 | 1.08 | 1.08 |
| Debt Service Coverage Ratio | 0.00 | 23799.50 | -3146.73 | -35.93 | -39.54 |
| Interest Coverage Ratio | 0.00 | 8071.00 | -5719.67 | -207.48 | -339.85 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.50 | 0.66 | 0.17 | 0.21 | 0.28 |
| Net Debt to EBITDA | -3.60 | -3.83 | 4.13 | 19.99 | 2.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.62% | 66.88% | 68.73% | 65.74% | 66.11% |
| EBIT Margin | 13.19% | 5.78% | -21.22% | -12.22% | -37.09% |
| EBITDA Margin | 17.33% | 11.04% | -13.68% | -2.35% | -27.42% |
| Operating Profit Margin | 14.34% | 3.62% | -23.76% | -13.85% | -37.31% |
| Pretax Profit Margin | 13.19% | 5.78% | -21.22% | -12.28% | -37.20% |
| Net Profit Margin | 12.83% | 5.41% | -20.61% | -12.33% | -34.42% |
| Continuous Operations Profit Margin | 12.83% | 5.41% | -20.61% | -12.33% | -34.42% |
| Net Income Per EBT | 97.29% | 93.76% | 97.12% | 100.37% | 92.55% |
| EBT Per EBIT | 91.98% | 159.48% | 89.30% | 88.67% | 99.69% |
| Return on Assets (ROA) | 4.72% | 1.86% | -6.67% | -3.16% | -6.36% |
| Return on Equity (ROE) | 5.07% | 2.05% | -7.13% | -3.40% | -6.89% |
| Return on Capital Employed (ROCE) | 5.51% | 1.32% | -8.14% | -3.76% | -7.29% |
| Return on Invested Capital (ROIC) | 5.34% | 1.23% | -7.87% | -3.74% | -6.72% |
| Return on Tangible Assets | 12.07% | 5.34% | -23.01% | -12.80% | -27.26% |
| Earnings Yield | 2.01% | 0.80% | -3.72% | -2.15% | -2.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.58 | 9.58 | 8.94 | 6.74 | 5.29 |
| Payables Turnover | 34.20 | 17.10 | 8.72 | 8.53 | 6.02 |
| Inventory Turnover | 7.65 | 6.79 | 7.00 | 7.11 | 6.63 |
| Fixed Asset Turnover | 8.80 | 6.27 | 11.70 | 9.61 | 7.05 |
| Asset Turnover | 0.37 | 0.34 | 0.32 | 0.26 | 0.18 |
| Working Capital Turnover Ratio | 1.43 | 1.72 | 1.76 | 1.62 | 0.82 |
| Cash Conversion Cycle | 68.59 | 70.53 | 51.12 | 62.75 | 63.37 |
| Days of Sales Outstanding | 31.52 | 38.10 | 40.82 | 54.18 | 68.94 |
| Days of Inventory Outstanding | 47.74 | 53.78 | 52.14 | 51.36 | 55.07 |
| Days of Payables Outstanding | 10.67 | 21.35 | 41.84 | 42.80 | 60.64 |
| Operating Cycle | 79.26 | 91.87 | 92.96 | 105.55 | 124.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.73 | 0.98 | 0.61 | 0.11 | -0.47 |
| Free Cash Flow Per Share | 1.61 | 0.83 | 0.47 | -0.01 | -0.54 |
| Dividend Paid and CapEx Coverage Ratio | 14.09 | 6.65 | 4.44 | 0.88 | -5.88 |
| Capital Expenditure Coverage Ratio | 14.09 | 6.65 | 4.44 | 0.88 | -5.88 |
| Operating Cash Flow Coverage Ratio | 3.44 | 1.48 | 3.50 | 0.51 | -1.68 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.17 | 0.12 | 0.03 | -0.14 |
| Free Cash Flow Yield | 3.83% | 2.11% | 1.71% | -0.06% | -1.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 50.12 | 123.75 | -26.86 | -46.44 | -37.02 |
| Price-to-Sales (P/S) Ratio | 6.40 | 6.79 | 5.54 | 5.73 | 12.74 |
| Price-to-Book (P/B) Ratio | 2.53 | 2.58 | 1.91 | 1.58 | 2.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 26.13 | 47.47 | 58.33 | -1674.42 | -75.60 |
| Price-to-Operating Cash Flow Ratio | 24.27 | 40.33 | 45.19 | 225.33 | -88.46 |
| Price-to-Earnings Growth (PEG) Ratio | 0.31 | -0.94 | -0.27 | 0.86 | -0.54 |
| Enterprise Value Multiple | 33.31 | 57.73 | -36.32 | -223.22 | -43.91 |
| Enterprise Value | 2.99B | 2.84B | 1.79B | 1.56B | 2.64B |
| EV to EBITDA | 33.31 | 57.73 | -36.32 | -223.22 | -43.91 |
| EV to Sales | 5.77 | 6.37 | 4.97 | 5.26 | 12.04 |
| EV to Free Cash Flow | 23.58 | 44.51 | 52.38 | -1536.82 | -71.43 |
| EV to Operating Cash Flow | 21.90 | 37.82 | 40.58 | 206.81 | -83.58 |
| Tangible Book Value Per Share | 5.77 | 4.29 | 3.48 | 2.86 | 2.74 |
| Shareholders’ Equity Per Share | 16.66 | 15.38 | 14.37 | 15.03 | 16.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.06 | 0.03 | -0.00 | 0.07 |
| Revenue Per Share | 6.58 | 5.83 | 4.97 | 4.14 | 3.23 |
| Net Income Per Share | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 |
| Tax Burden | 0.97 | 0.94 | 0.97 | 1.00 | 0.93 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.14 | 0.16 | 0.16 | 0.14 | 0.14 |
| SG&A to Revenue | 0.41 | 0.46 | 0.44 | 0.26 | 0.46 |
| Stock-Based Compensation to Revenue | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 |
| Income Quality | 2.05 | 3.11 | -0.59 | -0.21 | 0.42 |
Currency in USD
